← All organizations
Highest phase reached
Phase 4
First clinical trial
Aug 1, 2011Last known activity
Mar 15, 2018
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 3 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
Recent trials (10)
- NCT03456154Lead sponsorPhase 4Mar 15, 2018
- NCT03456154Reponsible party - principal investigatorPhase 4Mar 15, 2018
- NCT01906242Reponsible party - principal investigatorN/AApr 30, 2013
- NCT01906242Study chairN/AApr 30, 2013
- NCT01906242Lead sponsorN/AApr 30, 2013
- NCT01906242Overall official - principal investigatorN/AApr 30, 2013
- NCT01657539Study chairPhase 2/Phase 3Aug 1, 2011
- NCT01657539Lead sponsorPhase 2/Phase 3Aug 1, 2011
- NCT01657539Reponsible party - principal investigatorPhase 2/Phase 3Aug 1, 2011
- NCT01657539Overall official - principal investigatorPhase 2/Phase 3Aug 1, 2011
Details
- Last known activity
- Mar 15, 2018